PAR 5.10% 25.8¢ paradigm biopharmaceuticals limited..

research reports and media, page-1314

  1. 1,196 Posts.
    lightbulb Created with Sketch. 53
    So tell me mate this share is a fair way off for approvals?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.